Inventor
ALEKSANDRA RUDNITSKAYA
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes21%
Y02ATechnologies for adaptation to climate change14%
C07CAcyclic or carbocyclic compounds7%
PatentTitleYear
12,479,807Methods using HDAC11 inhibitors202512,304,904Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors202512,264,1373-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202511,919,839Alpha-cinnamide compounds and compositions as HDAC8 inhibitors202411,891,3653-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202411,702,412Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors202311,535,607Isoindolines as HDAC inhibitors202211,414,392[6,6] fused bicyclic HDAC8 inhibitors202211,345,672Methods using HDAC11 inhibitors202211,279,6813-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202211,274,0853-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202211,274,0843-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to VALO HEALTH INC (12)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VALO HEALTH INC | 12 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2022–2025 |